Ankündigung • Jun 30
Shanghai GenTech Co., Ltd. to Report First Half, 2026 Results on Aug 27, 2026 Shanghai GenTech Co., Ltd. announced that they will report first half, 2026 results on Aug 27, 2026 New Risk • May 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.3x net interest cover). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.5% net profit margin). Reported Earnings • Apr 20
First quarter 2026 earnings released: CN¥0.09 loss per share (vs CN¥0.12 profit in 1Q 2025) First quarter 2026 results: CN¥0.09 loss per share (down from CN¥0.12 profit in 1Q 2025). Revenue: CN¥970.1m (up 43% from 1Q 2025). Net loss: CN¥25.6m (down 174% from profit in 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 11% per year. Ankündigung • Apr 17
Shanghai GenTech Co., Ltd., Annual General Meeting, May 08, 2026 Shanghai GenTech Co., Ltd., Annual General Meeting, May 08, 2026, at 15:00 China Standard Time. Location: The Company's Meeting Room, Shanghai China Ankündigung • Mar 30
Shanghai GenTech Co., Ltd. to Report Q1, 2026 Results on Apr 18, 2026 Shanghai GenTech Co., Ltd. announced that they will report Q1, 2026 results on Apr 18, 2026 Reported Earnings • Mar 05
Full year 2025 earnings released: EPS: CN¥0.48 (vs CN¥1.88 in FY 2024) Full year 2025 results: EPS: CN¥0.48 (down from CN¥1.88 in FY 2024). Revenue: CN¥4.92b (down 10.0% from FY 2024). Net income: CN¥138.0m (down 74% from FY 2024). Profit margin: 2.8% (down from 9.6% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Ankündigung • Dec 26
Shanghai GenTech Co., Ltd. to Report Fiscal Year 2025 Results on Apr 18, 2026 Shanghai GenTech Co., Ltd. announced that they will report fiscal year 2025 results on Apr 18, 2026 New Risk • Nov 13
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (1.9% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.0% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.1% net profit margin). Valuation Update With 7 Day Price Move • Nov 06
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥31.86, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 41x in the Semiconductor industry in China. Total loss to shareholders of 17% over the past three years. New Risk • Oct 31
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 1.9% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (1.9% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.1% average weekly change). Profit margins are more than 30% lower than last year (5.1% net profit margin). Reported Earnings • Oct 31
Third quarter 2025 earnings released: CN¥0.081 loss per share (vs CN¥0.81 profit in 3Q 2024) Third quarter 2025 results: CN¥0.081 loss per share (down from CN¥0.81 profit in 3Q 2024). Revenue: CN¥1.28b (down 23% from 3Q 2024). Net loss: CN¥22.9m (down 110% from profit in 3Q 2024). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 26% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Oct 20
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥40.90, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 43x in the Semiconductor industry in China. Total returns to shareholders of 2.4% over the past three years. Ankündigung • Sep 30
Shanghai GenTech Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025 Shanghai GenTech Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025 Valuation Update With 7 Day Price Move • Sep 04
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥34.55, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 39x in the Semiconductor industry in China. Total loss to shareholders of 5.7% over the past three years. Ankündigung • Jun 30
Shanghai GenTech Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025 Shanghai GenTech Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 Declared Dividend • Jun 25
Dividend reduced to CN¥0.28 Dividend of CN¥0.28 is 2.4% lower than last year. Ex-date: 27th June 2025 Payment date: 27th June 2025 Dividend yield will be 0.8%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is covered by both earnings (15% earnings payout ratio) and cash flows (67% cash payout ratio). The dividend has increased by an average of 29% per year over the past 4 years. However, payments have been volatile during that time. EPS is expected to grow by 121% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Ankündigung • May 23
Shanghai GenTech Co., Ltd., Annual General Meeting, Jun 13, 2025 Shanghai GenTech Co., Ltd., Annual General Meeting, Jun 13, 2025, at 13:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China Reported Earnings • Apr 30
First quarter 2025 earnings released: EPS: CN¥0.12 (vs CN¥0.09 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.12 (up from CN¥0.09 in 1Q 2024). Revenue: CN¥676.7m (up 15% from 1Q 2024). Net income: CN¥34.4m (up 38% from 1Q 2024). Profit margin: 5.1% (up from 4.2% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year whereas the company’s share price has increased by 34% per year. Ankündigung • Mar 28
Shanghai GenTech Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Shanghai GenTech Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Reported Earnings • Mar 02
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: CN¥1.88 (up from CN¥1.47 in FY 2023). Revenue: CN¥5.47b (up 43% from FY 2023). Net income: CN¥528.0m (up 32% from FY 2023). Profit margin: 9.7% (in line with FY 2023). Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 2.8%. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Ankündigung • Dec 27
Shanghai GenTech Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025 Shanghai GenTech Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025 Ankündigung • Dec 06
Shanghai GenTech Co., Ltd. (SHSE:688596) agreed to acquire an additional 30.50% stake in Hongge Semiconductor Equipment (Shanghai) Co., Ltd. from LIU ERZHUANG, Tian Linlin, Hong Kong Fengge, Xu Zhiyong, Jiehongye, and Zhang Xiaomei for approximately CNY 340 million. Shanghai GenTech Co., Ltd. (SHSE:688596) agreed to acquire an additional 30.50% stake in Hongge Semiconductor Equipment (Shanghai) Co., Ltd. from LIU ERZHUANG, Tian Linlin, Hong Kong Fengge Co., Ltd., Xu Zhiyong, Jiehongye Co., Ltd., and Zhang Xiaomei for approximately CNY 340 million on December 3, 2024. Upon completion, Shanghai GenTech Co., Ltd. will own 90.50% stake in Hongge Semiconductor Equipment (Shanghai) Co., Ltd. The transaction will be financed through equity investment of CNY 335.67 million. As of September 30, 2024, Hongge Semiconductor Equipment (Shanghai) Co., Ltd. reported total assets of CNY 747.01 million and total common equity of CNY 392.61 million. The transaction is subject to approval of offer by acquirer board. The deal has been approved by the board. Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: CN¥0.80 (vs CN¥0.45 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.80 (up from CN¥0.45 in 3Q 2023). Revenue: CN¥1.65b (up 55% from 3Q 2023). Net income: CN¥226.7m (up 88% from 3Q 2023). Profit margin: 14% (up from 11% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥32.48, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 32x in the Semiconductor industry in China. Total returns to shareholders of 48% over the past three years. Ankündigung • Sep 30
Shanghai GenTech Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Shanghai GenTech Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥29.41, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 27x in the Semiconductor industry in China. Total returns to shareholders of 37% over the past three years. New Risk • Sep 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (33% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.8% average weekly change). Shareholders have been diluted in the past year (3.1% increase in shares outstanding). Reported Earnings • Aug 30
Second quarter 2024 earnings released: EPS: CN¥0.29 (vs CN¥0.53 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.29 (down from CN¥0.53 in 2Q 2023). Revenue: CN¥1.26b (up 35% from 2Q 2023). Net income: CN¥80.0m (down 42% from 2Q 2023). Profit margin: 6.3% (down from 15% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 29
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥28.04, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 30x in the Semiconductor industry in China. Total returns to shareholders of 20% over the past three years. Ankündigung • Jul 09
Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 50 million worth of its shares. Shanghai GenTech Co., Ltd. (SHSE:688596) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be purchased at a price not exceeding CNY 40 per share. The purpose of the program is to establish and improve the company's long-term incentive mechanism, fully mobilize the enthusiasm of the company's employees, effectively combine the interests of shareholders, the company and the personal interests of employees, and promote the healthy and sustainable development of the company. The repurchased shares will be used for employee stock ownership plans or equity incentive plans, otherwise will be cancelled if the company fails to transfer them within the time limit stipulated by relevant laws and regulations. The program will be funded from company's own funds. The program will be valid for 6 months. Ankündigung • Jun 28
Shanghai GenTech Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024 Shanghai GenTech Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024 Price Target Changed • Jun 06
Price target decreased by 9.8% to CN¥46.00 Down from CN¥51.00, the current price target is provided by 1 analyst. New target price is 36% above last closing price of CN¥33.79. Stock is down 8.7% over the past year. The company is forecast to post earnings per share of CN¥2.08 for next year compared to CN¥1.47 last year. New Risk • May 23
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.9% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (28% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Shareholders have been diluted in the past year (3.2% increase in shares outstanding). Reported Earnings • May 01
First quarter 2024 earnings released: EPS: CN¥0.09 (vs CN¥0.04 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.09 (up from CN¥0.04 in 1Q 2023). Revenue: CN¥588.7m (up 43% from 1Q 2023). Net income: CN¥24.9m (up 123% from 1Q 2023). Profit margin: 4.2% (up from 2.7% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 30% p.a. on average during the next 2 years, compared to a 23% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has increased by 37% per year whereas the company’s share price has increased by 38% per year. Ankündigung • May 01
Shanghai GenTech Co., Ltd., Annual General Meeting, May 24, 2024 Shanghai GenTech Co., Ltd., Annual General Meeting, May 24, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China Board Change • Apr 17
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Yue Liu was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Mar 30
Shanghai GenTech Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Shanghai GenTech Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Reported Earnings • Feb 24
Full year 2023 earnings: EPS exceeds analyst expectations Full year 2023 results: EPS: CN¥1.47 (up from CN¥1.01 in FY 2022). Revenue: CN¥3.84b (up 42% from FY 2022). Net income: CN¥401.7m (up 55% from FY 2022). Profit margin: 11% (in line with FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.1%. Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has increased by 36% per year whereas the company’s share price has increased by 31% per year. Ankündigung • Feb 08
Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 50 million worth of its shares. Shanghai GenTech Co., Ltd. (SHSE:688596) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its A shares. The shares will be repurchased at a price not more than CNY 40 per share. The repurchased shares will all be used for employee stock ownership plans or equity incentives. The company will use its own funds or self-raised funds to repurchase its shares. The program is valid for 6 months. New Risk • Feb 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (2.4% increase in shares outstanding). Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥30.88, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 25x in the Semiconductor industry in China. Total returns to shareholders of 106% over the past three years. Reported Earnings • Oct 26
Third quarter 2023 earnings released: EPS: CN¥0.45 (vs CN¥0.33 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.45 (up from CN¥0.33 in 3Q 2022). Revenue: CN¥1.07b (up 24% from 3Q 2022). Net income: CN¥120.8m (up 43% from 3Q 2022). Profit margin: 11% (up from 9.8% in 3Q 2022). Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 25% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Price Target Changed • Sep 02
Price target decreased by 9.4% to CN¥52.00 Down from CN¥57.37, the current price target is an average from 2 analysts. New target price is 41% above last closing price of CN¥36.92. Stock is up 23% over the past year. The company is forecast to post earnings per share of CN¥1.44 for next year compared to CN¥1.01 last year. Reported Earnings • Aug 25
Second quarter 2023 earnings released: EPS: CN¥0.52 (vs CN¥0.19 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.52 (up from CN¥0.19 in 2Q 2022). Revenue: CN¥933.6m (up 61% from 2Q 2022). Net income: CN¥138.6m (up 234% from 2Q 2022). Profit margin: 15% (up from 7.2% in 2Q 2022). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 24% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 26
First quarter 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.04 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.04 (in line with 1Q 2022). Revenue: CN¥410.8m (up 13% from 1Q 2022). Net income: CN¥11.1m (down 1.0% from 1Q 2022). Profit margin: 2.7% (down from 3.1% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 30% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Valuation Update With 7 Day Price Move • Mar 28
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥32.99, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 39x in the Semiconductor industry in China. Total returns to shareholders of 70% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.84 per share. Price Target Changed • Mar 15
Price target decreased by 12% to CN¥50.50 Down from CN¥57.37, the current price target is an average from 2 analysts. New target price is 31% above last closing price of CN¥38.48. Stock is up 86% over the past year. The company is forecast to post earnings per share of CN¥1.39 for next year compared to CN¥1.01 last year. Valuation Update With 7 Day Price Move • Mar 09
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥38.80, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 38x in the Semiconductor industry in China. Total returns to shareholders of 77% over the past year. Reported Earnings • Feb 15
Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2022 results: EPS: CN¥1.01 (up from CN¥0.66 in FY 2021). Revenue: CN¥2.70b (up 47% from FY 2021). Net income: CN¥258.5m (up 54% from FY 2021). Profit margin: 9.6% (in line with FY 2021). Revenue missed analyst estimates by 3.1%. Earnings per share (EPS) exceeded analyst estimates by 3.1%. Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 25% growth forecast for the Semiconductor industry in China. Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥47.53, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 34x in the Semiconductor industry in China. Total returns to shareholders of 106% over the past year. Reported Earnings • Oct 31
Third quarter 2022 earnings released: EPS: CN¥0.33 (vs CN¥0.21 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.33 (up from CN¥0.21 in 3Q 2021). Revenue: CN¥860.8m (up 92% from 3Q 2021). Net income: CN¥84.4m (up 58% from 3Q 2021). Profit margin: 9.8% (down from 12% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 26% growth forecast for the Semiconductor industry in China. Valuation Update With 7 Day Price Move • Oct 21
Investor sentiment improved over the past week After last week's 25% share price gain to CN¥40.38, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 32x in the Semiconductor industry in China. Total returns to shareholders of 80% over the past year. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥43.00, the stock trades at a forward P/E ratio of 33x. Average forward P/E is 31x in the Semiconductor industry in China. Total returns to shareholders of 112% over the past year. Valuation Update With 7 Day Price Move • Aug 29
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥29.35, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 36x in the Semiconductor industry in China. Total returns to shareholders of 10% over the past year. Reported Earnings • Aug 20
Second quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.23 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.19 (down from CN¥0.23 in 2Q 2021). Revenue: CN¥580.9m (down 5.7% from 2Q 2021). Net income: CN¥41.6m (down 22% from 2Q 2021). Profit margin: 7.2% (down from 8.7% in 2Q 2021). Over the next year, revenue is forecast to grow 59%, compared to a 49% growth forecast for the Semiconductor industry in China. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment improved over the past week After last week's 25% share price gain to CN¥27.60, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 40x in the Semiconductor industry in China. Total returns to shareholders of 19% over the past year. Valuation Update With 7 Day Price Move • Jul 22
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥20.44, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 39x in the Semiconductor industry in China. Total loss to shareholders of 11% over the past year. Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥20.80, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 36x in the Semiconductor industry in China. Total returns to shareholders of 21% over the past year. Ankündigung • May 28
Shanghai GenTech Co., Ltd. announced that it expects to receive CNY 300 million in funding Shanghai GenTech Co., Ltd. announced a private placement of A shares for gross proceeds not more than CNY 300,000,000 on May 27, 2022. The issue price shall not be lower than 80% of the average stock trading price of the 20 trading days prior to the pricing benchmark date. The transaction will include participation from not more than 35 investors. The transaction has been approved in the 11th meeting of the 3rd board of directors. The transaction is subject to approval of Shanghai Stock Exchange and China Securities Regulatory Commission. All securities issued in the transaction have a hold period of 18 months. Reported Earnings • Apr 29
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2022 results: EPS: CN¥0.04 (up from CN¥0.003 in 1Q 2021). Revenue: CN¥362.2m (up 111% from 1Q 2021). Net income: CN¥11.3m (up CN¥10.4m from 1Q 2021). Profit margin: 3.1% (up from 0.5% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 8.3%. Earnings per share (EPS) missed analyst estimates by 5.7%. Over the next year, revenue is forecast to grow 43%, compared to a 44% growth forecast for the industry in China. Ankündigung • Mar 30
Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 120 million worth of its shares. Shanghai GenTech Co., Ltd. (SHSE:688596) announces a share repurchase program. Under the program, the company will repurchase up to CNY 120 million worth of its shares. The program is valid for 12 months. Reported Earnings • Feb 27
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2021 results: EPS: CN¥0.68 (up from CN¥0.58 in FY 2020). Revenue: CN¥1.83b (up 65% from FY 2020). Net income: CN¥175.7m (up 41% from FY 2020). Profit margin: 9.6% (down from 11% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.8%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 44%, compared to a 56% growth forecast for the industry in China. Valuation Update With 7 Day Price Move • Nov 11
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥27.93, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 48x in the Semiconductor industry in China. Total returns to shareholders of 21% over the past year. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.09 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥447.3m (up 94% from 3Q 2020). Net income: CN¥53.3m (up 175% from 3Q 2020). Profit margin: 12% (up from 8.4% in 3Q 2020). Reported Earnings • Aug 25
Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.17 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥615.9m (up 84% from 2Q 2020). Net income: CN¥53.3m (up 59% from 2Q 2020). Profit margin: 8.7% (down from 10.0% in 2Q 2020). Valuation Update With 7 Day Price Move • Aug 20
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥20.05, the stock trades at a trailing P/E ratio of 37x. Average trailing P/E is 75x in the Semiconductor industry in China. Total loss to shareholders of 40% over the past year. Valuation Update With 7 Day Price Move • Aug 04
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥25.12, the stock trades at a trailing P/E ratio of 46.4x. Average trailing P/E is 76x in the Semiconductor industry in China. Valuation Update With 7 Day Price Move • Jul 12
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥21.38, the stock trades at a trailing P/E ratio of 39.5x. Average trailing P/E is 79x in the Semiconductor industry in China. Reported Earnings • Apr 20
First quarter 2021 earnings released: EPS CN¥0.003 (vs CN¥0.07 in 1Q 2020) The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥172.0m (down 23% from 1Q 2020). Net income: CN¥855.2k (down 94% from 1Q 2020). Profit margin: 0.5% (down from 6.0% in 1Q 2020). The decrease in margin was driven by lower revenue. Reported Earnings • Feb 10
Full year 2020 earnings released: EPS CN¥0.48 (vs CN¥0.45 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: CN¥1.11b (down 6.7% from FY 2019). Net income: CN¥102.7m (up 24% from FY 2019). Profit margin: 9.3% (up from 7.0% in FY 2019). The increase in margin was driven by lower expenses. Is New 90 Day High Low • Feb 03
New 90-day low: CN¥15.90 The company is down 32% from its price of CN¥23.52 on 05 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 11% over the same period. Valuation Update With 7 Day Price Move • Jan 11
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥16.97, the stock is trading at a trailing P/E ratio of 28.8x, down from the previous P/E ratio of 34.4x. This compares to an average P/E of 77x in the Semiconductor industry in China. Is New 90 Day High Low • Jan 06
New 90-day low: CN¥18.86 The company is down 19% from its price of CN¥23.23 on 30 September 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 20% over the same period. Is New 90 Day High Low • Dec 16
New 90-day low: CN¥20.75 The company is down 21% from its price of CN¥26.15 on 17 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 9.0% over the same period. Ankündigung • Oct 29
Shanghai GenTech Co., Ltd. to Report Q3, 2020 Results on Oct 30, 2020 Shanghai GenTech Co., Ltd. announced that they will report Q3, 2020 results on Oct 30, 2020 
